A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.
The ability to extract insights from big data is quickly becoming a key factor for competitive advantage in every industry, and Life Sciences is no different.